期刊文献+

Graves病动物模型干预模式的探讨 被引量:6

Effects of time and immunization on the animal model of Graves′ disease
下载PDF
导出
摘要 目的研究造模时间及免疫次数对促甲状腺激素受体(TSHR)A亚单位的重组腺病毒(Ad-TSHR289)诱导的毒性弥漫性甲状腺肿(Graves病)模型的影响。方法 45只BALB/c小鼠分别注射对照腺病毒(Ad-Lacz)或AdTSHR289,于第2次免疫后2周或第3次免疫后4周处死。所有小鼠均采取摘眼球取血,放免法检测血清促甲状腺激素受体抗体(TRAb)以及总甲状腺素(TT4)水平;剥离甲状腺,进行组织学检查。结果所有注射Ad-TSHR289的小鼠相对于对照组TRAb均明显升高;5周-造模组、10周-造模组的Graves病发病率分别为56%(9/16)、75%(9/12);10周-造模组甲状腺组织学改变与TT4水平变化吻合度为100%,相对于5周-造模组的50%(8/16)明显升高。结论 10周-造模组相对于5周-造模组具有发病率高、组织学改变与血清TT4水平吻合度高等优势;造模时间以及免疫次数均对该Graves病模型有着较大的影响。 Objective To investigate the effects of time and immunization frequency of administration of Ad- TSHR289 on the development of a Graves' disease (GD) animal model. Methods BALB/c mice were injected with Ad-TSHR289 or Ad-lacz twice (5 week) or thrice (10 week) at three-weekly intervals. Blood and thyroid glands were obtained 2 weeks or ~ weeks after iniection. Total thyroxine (TT4) and thyrotropin receptor autoantibody (TRAb) levels were measured by radioimmutaoassay (RIA). Results TRAb significantly increased in all the mice injected with Ad-TSHR289 compared with the controls. The incidence of GD was 56% (9/16) in 5- week model group and 75% (9/12) in 10-week model group. The consistency between serum TT4 level and histological changes of the thyroid was 50% in 5-week model group and 100% in 10-week model group, respectively. Conclusion Ten-week intervention is more effective than 5-week one in inducing a GD animal model. Intervention time and immunization frequency are two important factors affecting the development of a GD animal model induced by Ad-TSHR289.
出处 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2014年第2期222-226,共5页 Journal of Xi’an Jiaotong University(Medical Sciences)
基金 国家自然科学基金资助项目(No.81200574)~~
关键词 Ad-TSHR289 GRAVES病 自身免疫性疾病 动物模型 发病率 Ad-TSHR289 Graves' disease (GD) autoimmune disease animal model incidence
  • 相关文献

参考文献16

  • 1王悦,伍丽萍,施秉银.Graves病动物模型研究进展[J].医学综述,2012,18(10):1455-1458. 被引量:4
  • 2CHEN CR, PICHURIN P, NAGAYAMA Y, et al. The thy- rotropin receptor autoantigen in Graves disease is the culprit as well as the victim [J]. J Clin Invest, 2003, 111 (12), 1897- 1904.
  • 3CHEN CR, ALIESKY HA, GUO J, et al. Blockade of costim- ulation between T cells and antigen-presenting cells: an ap- proach to suppress murine Graves' disease induced using thyrot- ropin receptor-expressing adenovirus [J]. Thyroid, 2006, 16 (5) :427-434.
  • 4SAITOH O, NAGAYAMA Y. Regulation of graves' hyperthy- roidism with naturally occurring CD4+ CD25+ regulatory T cells in a mouse model~[J]. Endocrinology, 2006, 147(5) :2417- 2422.
  • 5UEKI I, ABIRU N, KOBAYASHI M, et al. B cell-targeted therapy with anti-CD20 monoclonal antibody in a mouse model of Graves' hyperthyroidism~[J]. Clin Exp Immunol, 2011, 163 (3) :309-317.
  • 6NAGAYAMA Y, SAITOH O, MCLACHLAN SM, et al. TSH receptor-adenovirus-induced Graves' hyperthyroidism is attenu-ated in both interferon-gamma and interleukin-4 knockout mice; ~mplications for the Thl/Th2 paradigm[J]. Clin Exp [m- munol, 2004, 138(3)~417-422.
  • 7SAITOH O, MIZUTORI Y, TAKAMURA N, et al. Adenovi- rus-mediated gene delivery of interleukin-10, but not transfor- ming growth factor beta, ameliorates the induction of Graves' hyperthyroidism in BALB/c mice [J]. Clin Exp Immunol, 2005, 141(3) :405-411.
  • 8YE F, HOU P, WU X, et al. The significance of immune-re- lated molecule expression profiles in an animal model of Graves' disease~l]. Autoimmunity, 2012, 45(2) :143-152.
  • 9UEKI I, ABIRU N, KAWAGOE K, et al. Interleukin 10 defi- ciency attenuates induction of anti-TSH receptor antibodies and hyperthyroidism in a mouse Graves' model[J]. J Endocrinol, 2011, 209(3) :353-357.
  • 10WU L, XUN L, YANG J, et al. Induction of murine neonatal tolerance against Graves' disease using recombinant adenovirus expressing the TSH receptor A-subunit [J]. Endocrinology, 2011, 152(3) :1165-1171.

二级参考文献37

  • 1伍丽萍,施秉银,郭丽英,徐利,兰玲,刘娟,张进安,旬利茹.在雌性小鼠制备Graves病动物模型[J].中华内分泌代谢杂志,2006,22(4):388-391. 被引量:15
  • 2Shimojo N, Kohno Y, Yamaguchi K, et al. Induction of graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin repector and a class Ⅱ molecule [ J ]. Proc NatlAcad Sci U S A,1996,93(20) :11074-11079.
  • 3Kita M,Ahmad L, Marians RC, et al. Regulation and transfer of a routine model of thyrotropin receptor antibody mediated Graves' disease [ J ]. Endocrinology, 1999,140 (3) : 1392-1398.
  • 4Rao PV, Watson PF, Weetman AP, et al. Contrasting activities of thyrotropin receptor antibodies in experimental models of Graves'dis ease induced by injection of transfected fibroblasts or deoxyribonu- cleic acid vaccination[ J].Endocrinology,2003,144( 1 ) :260-266.
  • 5Ando T, Imaizumi M, Graves P, et al. Induction of thyroid-stimulating hormone receptor autoimmunity in hamsters [ J ]. Endocrinology,2003,144(2) :671-680.
  • 6Kaithamana S, Fan J, Osuga Y, et al. Induction of experimental autoimmune Graves'disease in BALB/c mice [J]. J Immunol, 1999, 163(9) :5157-5164.
  • 7Costagliola S, Rodien P, Many MC, et al. Genetic immunization against the human thyrotropin receptor causes thyroiditis and allows production of monoclonal antibodies recognizing the native receptor [J]. J Immunol, 1998,160 (3) : 1458-1465.
  • 8Barrett K, Liakata E, Rao PV, et al. Induction of hyperthyroidism in mice by intradermal immunization with DNA encoding the thyrotro- pin receptor [J]. Clin Exp Immuno1,2004,136 ( 3 ) :413-422.
  • 9Costagliola S, Many MC, Denef JF, et al. Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease[J]. J Clin Invest,2000,105(6) :803-811.
  • 10Pichurin P, Yan XM, Farilla L, et al. Naked TSH receptor DNA vaceination:A TH1 T cell response in which interferon-gamma pro- duction, rather than antibody, dominates the immune response in mice [ J]. Endocrinology,2001,142 ( 8 ) :3530-3536.

共引文献16

同被引文献60

引证文献6

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部